Costs of breast cancer care in Mexico: analysis of two insurance coverage scenarios

Abstract

BackgroundBreast cancer (BC) is a major cause of disease and death worldwide. In addition to its contribution to mortality and disability, it is a major economic burden both public and private.ObjectiveTo estimate the average direct medical cost/year of care for the diagnosis and treatment of BC in two coverage scenarios in Mexico: What is ‘ideal’ based on service usage patterns according to international guidelines and what is ‘current’ using the service usage patterns of suppliers in Mexico.Material and MethodsThe pattern and intensity of use of procedures for the care of BC in the Mexican Social Security Institute (IMSS) for 2009 were identified and prices were associated using the guidelines from the System of Social Protection in Health (SPSS) and the IMSS for the current scenario and the ideal scenario, international patterns (Breast Health Global Initiative BHGI after its acronym in English) were used and prices were associated from the SPSS guidelines.ResultsThe annual average direct medical cost per patient in the ‘current’ scenario was 8557 US$, while the cost in the ‘ideal’ scenario was 4554 US$. There are differences in costs between ‘what we do’ and ‘what should be done’, due to differences in the implementation of the interventions for the treatment of the different stages of the disease. A proportional increase in the average cost was also identified as the diagnosis stage advanced (from I to III).ConclusionsGiven that in Mexico there is universal insurance coverage for the treatment of BC, it is necessary to use economic resources more efficiently. It is necessary to continue to examine this topic in more depth and the next step will be to assess the effectiveness of both scenarios in order to provide enough evidence for the decision-making process.

Breast cancer early detection: A phased approach to implementation

“…The essential package funded in each country will depend on what is affordable. Governments may decide to offer subsidized care to a targeted population, or they may initially cover fewer interventions and increase them over time, as resource envelopes rise, as has been done in several LMICs, including Mexico 62 and Thailand 63,64 …”

Situational analysis of breast health care systems: Why context matters

“…Insufficient infrastructure, geographic location, limited workforce capacity, and chronic underfunding can result in health systems that are ill‐equipped to manage the epidemiologic transition from communicable to noncommunicable diseases. This is compounded by financial barriers to access, including a lack of health insurance and high out‐of‐pocket payments and indirect costs 14‐18 . Unfavorable outcomes also are influenced by sociocultural factors, such as stigma, myths, language barriers, gender norms, discrimination, social class, and health literacy 11,15,16,19 .…”

The burden of suboptimal breastfeeding in Mexico: Maternal health outcomes and costs

“…Recent evidence shows that women with shorter breastfeeding duration have an increased risk of breast and ovarian cancer, type 2 diabetes, hypertension, and myocardial infarction (MI; Bartick et al, ; Chowdhury et al, ). This is of special concern because these diseases are the leading causes of morbidity and mortality in Mexican women (Gomez‐Dantes et al, ) and represent a high economic burden for the health system (Figueroa‐Lara, Gonzalez‐Block, & Alarcon‐Irigoyen, ; Gonzalez‐Robledo, Wong, Ornelas, & Knaul, ) and society (Barraza‐Lloréns et al, ).…”